Jeffrey B. Mirviss - Feb 13, 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 13, 2025
Transactions value $
-$439,508
Form type
4
Date filed
2/18/2025, 05:52 PM
Previous filing
Feb 14, 2025
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2.78K +9.35% $0.00 32.5K Feb 14, 2025 Direct F1
transaction BSX Common Stock Tax liability -$134K -1.27K -3.9% $106.11 31.2K Feb 14, 2025 Direct
transaction BSX Common Stock Options Exercise $0 +2.97K +9.52% $0.00 34.2K Feb 16, 2025 Direct F1
transaction BSX Common Stock Tax liability -$144K -1.36K -3.96% $106.11 32.8K Feb 16, 2025 Direct
transaction BSX Common Stock Options Exercise $0 +3.33K +10.16% $0.00 36.2K Feb 17, 2025 Direct F1
transaction BSX Common Stock Tax liability -$161K -1.52K -4.21% $106.11 34.6K Feb 17, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +5.18K $0.00 5.18K Feb 13, 2025 Common Stock 5.18K Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +13.3K $0.00 13.3K Feb 13, 2025 Common Stock 13.3K $106.14 Direct F3
transaction BSX Restricted Stock Units Options Exercise $0 -2.78K -33.33% $0.00 5.55K Feb 14, 2025 Common Stock 2.78K Direct F1, F4
transaction BSX Restricted Stock Units Options Exercise $0 -2.97K -50% $0.00 2.97K Feb 16, 2025 Common Stock 2.97K Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -3.33K -100% $0.00 0 Feb 17, 2025 Common Stock 3.33K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.